EQUASENS (EQS.PA) Fundamental Analysis & Valuation

EPA:EQS • FR0012882389

Current stock price

39.95 EUR
+0.75 (+1.91%)
Last:

This EQS.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. EQS.PA Profitability Analysis

1.1 Basic Checks

  • In the past year EQS was profitable.
  • EQS had a positive operating cash flow in the past year.
  • EQS had positive earnings in each of the past 5 years.
  • EQS had a positive operating cash flow in each of the past 5 years.
EQS.PA Yearly Net Income VS EBIT VS OCF VS FCFEQS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

  • EQS has a better Return On Assets (8.82%) than 72.73% of its industry peers.
  • EQS has a better Return On Equity (15.77%) than 90.91% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 12.84%, EQS belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
  • EQS had an Average Return On Invested Capital over the past 3 years of 15.18%. This is significantly above the industry average of 7.85%.
Industry RankSector Rank
ROA 8.82%
ROE 15.77%
ROIC 12.84%
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
EQS.PA Yearly ROA, ROE, ROICEQS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 16.13%, EQS belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
  • EQS's Profit Margin has been stable in the last couple of years.
  • The Operating Margin of EQS (20.02%) is better than 81.82% of its industry peers.
  • In the last couple of years the Operating Margin of EQS has declined.
  • EQS's Gross Margin of 68.81% is in line compared to the rest of the industry. EQS outperforms 45.45% of its industry peers.
  • In the last couple of years the Gross Margin of EQS has remained more or less at the same level.
Industry RankSector Rank
OM 20.02%
PM (TTM) 16.13%
GM 68.81%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
EQS.PA Yearly Profit, Operating, Gross MarginsEQS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

6

2. EQS.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EQS is creating value.
  • The number of shares outstanding for EQS remains at a similar level compared to 1 year ago.
  • EQS has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, EQS has an improved debt to assets ratio.
EQS.PA Yearly Shares OutstandingEQS.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EQS.PA Yearly Total Debt VS Total AssetsEQS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 3.79 indicates that EQS is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.79, EQS is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
  • The Debt to FCF ratio of EQS is 0.98, which is an excellent value as it means it would take EQS, only 0.98 years of fcf income to pay off all of its debts.
  • EQS has a Debt to FCF ratio of 0.98. This is in the better half of the industry: EQS outperforms 72.73% of its industry peers.
  • EQS has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
  • EQS's Debt to Equity ratio of 0.09 is fine compared to the rest of the industry. EQS outperforms 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.98
Altman-Z 3.79
ROIC/WACC1.67
WACC7.69%
EQS.PA Yearly LT Debt VS Equity VS FCFEQS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • EQS has a Current Ratio of 1.29. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
  • EQS has a Current ratio of 1.29. This is comparable to the rest of the industry: EQS outperforms 45.45% of its industry peers.
  • EQS has a Quick Ratio of 1.20. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
  • EQS has a Quick ratio of 1.20. This is comparable to the rest of the industry: EQS outperforms 54.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.2
EQS.PA Yearly Current Assets VS Current LiabilitesEQS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. EQS.PA Growth Analysis

3.1 Past

  • The earnings per share for EQS have decreased strongly by -13.90% in the last year.
  • The Earnings Per Share has been growing slightly by 5.12% on average over the past years.
  • The Revenue has been growing slightly by 4.45% in the past year.
  • The Revenue has been growing slightly by 6.45% on average over the past years.
EPS 1Y (TTM)-13.9%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%

3.2 Future

  • Based on estimates for the next years, EQS will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.19% on average per year.
  • EQS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.74% yearly.
EPS Next Y9.47%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue Next Year9.26%
Revenue Next 2Y9.92%
Revenue Next 3Y9.04%
Revenue Next 5Y7.74%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EQS.PA Yearly Revenue VS EstimatesEQS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
EQS.PA Yearly EPS VS EstimatesEQS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

6

4. EQS.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 16.65 indicates a correct valuation of EQS.
  • Compared to the rest of the industry, the Price/Earnings ratio of EQS indicates a rather cheap valuation: EQS is cheaper than 81.82% of the companies listed in the same industry.
  • EQS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.21.
  • EQS is valuated correctly with a Price/Forward Earnings ratio of 13.16.
  • Based on the Price/Forward Earnings ratio, EQS is valued cheaper than 81.82% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.10, EQS is valued a bit cheaper.
Industry RankSector Rank
PE 16.65
Fwd PE 13.16
EQS.PA Price Earnings VS Forward Price EarningsEQS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EQS is valued cheaper than 81.82% of the companies in the same industry.
  • EQS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EQS is cheaper than 63.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.25
EV/EBITDA 7.88
EQS.PA Per share dataEQS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of EQS may justify a higher PE ratio.
  • EQS's earnings are expected to grow with 14.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.76
PEG (5Y)3.25
EPS Next 2Y15.06%
EPS Next 3Y14.19%

7

5. EQS.PA Dividend Analysis

5.1 Amount

  • EQS has a Yearly Dividend Yield of 3.65%.
  • Compared to an average industry Dividend Yield of 2.40, EQS pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, EQS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.65%

5.2 History

  • On average, the dividend of EQS grows each year by 8.00%, which is quite nice.
Dividend Growth(5Y)8%
Div Incr Years0
Div Non Decr Years2
EQS.PA Yearly Dividends per shareEQS.PA Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • EQS pays out 51.82% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • EQS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.82%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EQS.PA Yearly Income VS Free CF VS DividendEQS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
EQS.PA Dividend Payout.EQS.PA Dividend Payout, showing the Payout Ratio.EQS.PA Dividend Payout.PayoutRetained Earnings

EQS.PA Fundamentals: All Metrics, Ratios and Statistics

EQUASENS

EPA:EQS (4/8/2026, 3:33:30 PM)

39.95

+0.75 (+1.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-30
Earnings (Next)04-29
Inst Owners11.96%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap606.04M
Revenue(TTM)224.73M
Net Income(TTM)36.26M
Analysts83.33
Price Target54.06 (35.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.65%
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.82%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-3.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE 16.65
Fwd PE 13.16
P/S 2.7
P/FCF 16.25
P/OCF 12.42
P/B 2.64
P/tB 7.59
EV/EBITDA 7.88
EPS(TTM)2.4
EY6.01%
EPS(NY)3.04
Fwd EY7.6%
FCF(TTM)2.46
FCFY6.16%
OCF(TTM)3.22
OCFY8.05%
SpS14.81
BVpS15.16
TBVpS5.27
PEG (NY)1.76
PEG (5Y)3.25
Graham Number28.61
Profitability
Industry RankSector Rank
ROA 8.82%
ROE 15.77%
ROCE 15.76%
ROIC 12.84%
ROICexc 18.12%
ROICexgc 70.2%
OM 20.02%
PM (TTM) 16.13%
GM 68.81%
FCFM 16.6%
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.08%
ROICexc(5y)21.2%
ROICexgc(3y)48.92%
ROICexgc(5y)61.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexgc growth 3Y-28.73%
ROICexgc growth 5Y-12.2%
ROICexc growth 3Y-17.5%
ROICexc growth 5Y-11.29%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.98
Debt/EBITDA 0.32
Cap/Depr 70.06%
Cap/Sales 5.11%
Interest Coverage 250
Cash Conversion 79.48%
Profit Quality 102.89%
Current Ratio 1.29
Quick Ratio 1.2
Altman-Z 3.79
F-Score7
WACC7.69%
ROIC/WACC1.67
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.9%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
EPS Next Y9.47%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
Revenue Next Year9.26%
Revenue Next 2Y9.92%
Revenue Next 3Y9.04%
Revenue Next 5Y7.74%
EBIT growth 1Y-7%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year58.15%
EBIT Next 3Y25.89%
EBIT Next 5YN/A
FCF growth 1Y-36.45%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-30.97%
OCF growth 3Y0.02%
OCF growth 5Y3.18%

EQUASENS / EQS.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EQUASENS (EQS.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA.


What is the valuation status of EQUASENS (EQS.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to EQUASENS (EQS.PA). This can be considered as Fairly Valued.


How profitable is EQUASENS (EQS.PA) stock?

EQUASENS (EQS.PA) has a profitability rating of 7 / 10.


What is the valuation of EQUASENS based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EQUASENS (EQS.PA) is 16.65 and the Price/Book (PB) ratio is 2.64.


Is the dividend of EQUASENS sustainable?

The dividend rating of EQUASENS (EQS.PA) is 7 / 10 and the dividend payout ratio is 51.82%.